GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Ending Cash Position

Daito Pharmaceutical Co (TSE:4577) Ending Cash Position : 円0 Mil (As of Feb. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Ending Cash Position?

Daito Pharmaceutical Co's Ending Cash Position for the quarter that ended in Feb. 2024 was 円0 Mil.

Daito Pharmaceutical Co's annual Ending Cash Position increased from May. 2021 (円3,372 Mil) to May. 2022 (円4,381 Mil) but then declined from May. 2022 (円4,381 Mil) to May. 2023 (円3,607 Mil).


Daito Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Daito Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Ending Cash Position Chart

Daito Pharmaceutical Co Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,819.44 3,084.11 3,372.00 4,381.00 3,607.00

Daito Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Daito Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Daito Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in May. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=4382+-775
=3,607

Daito Pharmaceutical Co's Ending Cash Position for the quarter that ended in Feb. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0


Daito Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Daito Pharmaceutical Co (TSE:4577) Business Description

Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines